CYTOSORBENTS CORPORATION - COMMON STOCK

CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled

20 4 2023 07:00:01 提供 Nasdaq GlobeNewswire

CytoSorbents Announces Board Chairman Al W. Kraus To Retire

19 4 2023 07:00:00 提供 Nasdaq GlobeNewswire

Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation

29 3 2023 08:30:00 提供 Nasdaq GlobeNewswire

CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

22 3 2023 08:09:06 提供 Nasdaq GlobeNewswire

CytoSorbents Comments on Bank Exposure and Diversified Cash Position

14 3 2023 07:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

09 3 2023 16:15:00 提供 Nasdaq GlobeNewswire

New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time

07 3 2023 07:00:00 提供 Nasdaq GlobeNewswire